|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 801.10 INR | +0.53% |
|
-4.35% | -5.32% |
| 01-12 | Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Bosutinib Tablets, 400 Mg | CI |
| 01-12 | Alembic Pharmaceuticals Gets Tentative Nod from US FDA for Bosutinib Tablets | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LIMITED | Other Pharmaceuticals | +0.53% | -4.35% | -5.32% | -20.69% | -26.97% | 1.74B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- APLLTD Stock
- Charts Alembic Pharmaceuticals Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition